OTC Hearing Aid and MCI

Sponsor
Northwestern University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06112860
Collaborator
(none)
50
2
16.5

Study Details

Study Description

Brief Summary

The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids:

  1. improve communication

  2. Whether the magnitude of benefit depends on the patient's level of cognitive disability,

  3. Whether alternative remediation (such as targeted communication strategies) offer similar benefits.

Participants and a communication partner will be randomized into an OTC first or Communication Strategies first arm, where participants will receive communication strategy information customized for those with cognitive impairment.

Condition or Disease Intervention/Treatment Phase
  • Device: Over the counter hearing aid
  • Behavioral: Communication Strategies Information/Counseling
N/A

Detailed Description

This is a single blind cross-over study comparing OTC Hearing Aids to communication strategies information/counseling and their impact on communication between a person who has hearing loss and MCI and a communication partner. Due to the nature of the study, it will not be possible to blind the participants to which arm they are in, but the scorers will be blinded.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Those listening and scoring recorded tasks will be blinded to which group the participants are in.
Primary Purpose:
Treatment
Official Title:
Over-the-counter Hearing Aids and Mild Cognitive Impairment
Anticipated Study Start Date :
Mar 15, 2024
Anticipated Primary Completion Date :
Jan 31, 2025
Anticipated Study Completion Date :
Jul 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: OTC Hearing Aid First

Participants will be provided a pair of OTC hearing aids (experimental) with typical directions and use for 4 weeks before outcome measures will be assessed. After which, participants will then receive the communication strategies information/counseling (control) and have outcome measures assessed after 4 weeks.

Device: Over the counter hearing aid
An over the counter hearing aid is a device that provides amplification appropriate for individuals with mild to moderate hearing loss. Participants will receive the devices with typical directions and have one scheduled remote visit one week after receiving devices with an audiologist.
Other Names:
  • OTC hearing aid
  • Behavioral: Communication Strategies Information/Counseling
    Communication Strategies provide information meant to help an individual compensate for hearing loss. The information provides tips both for the individual with hearing loss and for those communicating. People who choose not to pursue hearing aids will typically be given communication strategies information to help them manage their hearing loss. Participants will receive the counseling information in the mail and then have a 1 week follow-up appointment with an audiologist.
    Other Names:
  • Communication Strategies
  • Other: Communication Strategies First

    Participants will receive the communication strategies information/counseling intervention (control) first. Outcome measures will be assessed at 4 weeks. After which, participants will then be given a pair of OTC hearing aids (experimental) with typical directions and use for four weeks before having outcome measures assessed.

    Device: Over the counter hearing aid
    An over the counter hearing aid is a device that provides amplification appropriate for individuals with mild to moderate hearing loss. Participants will receive the devices with typical directions and have one scheduled remote visit one week after receiving devices with an audiologist.
    Other Names:
  • OTC hearing aid
  • Behavioral: Communication Strategies Information/Counseling
    Communication Strategies provide information meant to help an individual compensate for hearing loss. The information provides tips both for the individual with hearing loss and for those communicating. People who choose not to pursue hearing aids will typically be given communication strategies information to help them manage their hearing loss. Participants will receive the counseling information in the mail and then have a 1 week follow-up appointment with an audiologist.
    Other Names:
  • Communication Strategies
  • Outcome Measures

    Primary Outcome Measures

    1. Communication partner-reported communication ability (PCI-DAT). [Baseline at enrollment, then after 4 weeks of using each intervention]

      A questionnaire completed by the communication partner of the individual with MCI and hearing loss. On this scale, higher scores reflect more frequent and more problematic conversation difficulties; item possible scores range from 0 (not problematic) to 7 (.very problematic)

    Secondary Outcome Measures

    1. Diapix [4 weeks after first intervention]

      A conversation task where participant and communication partner find the differences in two very similar pictures by discussing them.

    2. Hearing Handicap Inventory for the Elderly (HHIE) [Baseline at enrollment, then after 4 weeks of using each intervention]

      Questionnaire has 25 items with subscales for social and emotional impacts and is scored from 0-100, with 100 representing least handicap.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    60 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Over 60 years of age

    • Mild dementia or mild cognitive impairment. Diagnosis will be made at participating memory evaluation centers (see recruitment).

    • Mild to moderate bilateral hearing loss and no current hearing aid use.

    • A communication partner who is able and willing to participate in the study.

    • No vision impairment that would interfere with the ability to complete study tasks (i.e., legally blind, severe cataracts, or macular degeneration)

    • Able to provide own consent as evaluated by the Consent Assessment

    Exclusion Criteria:
    1. Clinically significant unstable or progressive medical conditions, or conditions which, in the opinion of the investigator(s) places the participant at unacceptable risk if he or she were to participate in the study.

    2. History of unresolved communication difficulties following another neurological problem (i.e., stroke or brain tumor), neurodevelopmental disorder (i.e., Down's syndrome), or head/neck cancer

    3. Positive history of major psychiatric disorder (i.e., schizophrenia, significant untreated depression)

    4. Co-enrolled in other intervention studies targeting hearing, language, or communication strategies.

    5. History or current fluctuating hearing loss

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Northwestern University

    Investigators

    • Principal Investigator: Pamela Souza, PhD, Northwestern University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Pamela Souza, Professor, Otolaryngology; Communication Sciences and Disorders, Northwestern University
    ClinicalTrials.gov Identifier:
    NCT06112860
    Other Study ID Numbers:
    • STU00219514
    First Posted:
    Nov 2, 2023
    Last Update Posted:
    Nov 7, 2023
    Last Verified:
    Nov 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Pamela Souza, Professor, Otolaryngology; Communication Sciences and Disorders, Northwestern University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 7, 2023